PS Ratio: 63.79

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 63.79 is 287% above its estimated 5-year average of 16.49, near the high end of its estimated 5-year range (3.37–83.96).

As of 2026-10-06T20:37:32.759Z. 218.29% above its estimated 12-month average of 20.04.

NRIX PS Ratio Metrics

P/S vs. estimated history

At 63.79, P/S is above its estimated 6-year median — higher than 92% of readings in its estimated 6-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Nurix Therapeutics, Inc. (NRIX)?

The P/S ratio for NRIX stock is 63.79.

Is Nurix Therapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 63.79 is 287% above its estimated 5-year average of 16.49, near the high end of its estimated 5-year range (3.37–83.96).

What is the estimated TTM average P/S ratio for Nurix Therapeutics, Inc. (NRIX)?

The estimated TTM average P/S ratio for NRIX stock is 20.04.

What is the estimated 3Y average P/S ratio for Nurix Therapeutics, Inc. (NRIX)?

The estimated 3Y average P/S ratio for NRIX stock is 16.80.

What is the estimated 5Y average P/S ratio for Nurix Therapeutics, Inc. (NRIX)?

The estimated 5Y average P/S ratio for NRIX stock is 16.49.

Showing the most recent 260 of 1,557 data points. The chart above shows the full history.

Related Metrics